This site is intended for healthcare professionals
Drug news

FDA accepts new drug application for UX 007 for treatment of long-chain fatty acid oxidation disorders.- Ultragenyx Pharmaceutical

Read time: 1 mins
Last updated:15th Oct 2019
Published:15th Oct 2019
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest